시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 충혈 완화제 시장 보고서(2025년)
Decongestants Global Market Report 2025
상품코드 : 1764294
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

충혈 완화제 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 대형, 온라인 약국의 보급 증가 등에 기인한다고 생각됩니다. 이 기간에 예상되는 주요 동향에는 드러그 딜리버리 시스템의 기술적 발전, 소아용 제제의 혁신, 서방형 제제의 개발, 알레르기에 특화한 치료법의 연구 개발, 천연 약초 대체품의 혁신 등이 있습니다.

알레르기, 감기, 부비동염의 이환율 증가는 충혈 완화제 시장의 향후 성장을 가속할 것으로 예측됩니다. 감염과 알레르기로 인한 부비동 염증입니다. 이 증상 증가는 대기 오염과 환경 자극 물질 증가와 관련이 있습니다. 어려움을 완화하고 환자의 편안함을 높임으로써 알레르기, 감기, 부비동염을 관리하는 데 도움이 됩니다. 예를 들어, 2023년 12월 미국의 비영리 단체인 USAFacts는 2022-2023년 미국 독감 시즌 동안 약 3,190만 명이 독감 증상을 경험했으며, 그 중 약 85%가 10월과 1월 사이에 발생했다고 보고했습니다.

충혈 완화제 시장의 주요 기업은 코 막힘을 신속하고 효과적으로 완화하고 사용자의 쾌적성과 치료 효과를 향상시키기 위해 즉효성 스프레이 등 시판 비강 충혈 제거제의 제품 확대에 주력하고 있습니다. 콧물 막힘을 신속하게 완화함으로써 신속한 완화를 제공하는 점비약입니다. 자일로메타졸린 코 막힘 해소 스프레이를 발매했습니다. 발매는 간편하고 고품질의 셀프 케어 치료를 제공하는 한편, 신속하고 장기적인 완화와 사용의 용이성을 실현하는 효과적인 충혈 완화제에 대한 소비자 수요의 고조에 부응하는 이 회사의 헌신적인 자세를 부각하는 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Decongestants are drugs used to alleviate nasal congestion caused by ailments such as the common cold, allergies, or sinus infections. They function by constricting blood vessels in the nasal passages, which reduces swelling and helps open the airways for easier breathing.

The primary forms of decongestants include tablets, capsules, nasal sprays, and other types. Tablets are solid oral medications that relieve nasal congestion by shrinking swollen blood vessels in the nasal passages. Decongestants are classified by their delivery method into topical, oral, and inhalation forms, each catering to specific needs like convenience, speed of effect, and symptom severity. These products are made using various ingredients, including synthetic decongestants that provide fast and targeted relief, as well as natural, plant-based options. Decongestants are used to treat several conditions, including seasonal allergic rhinitis, perennial allergic rhinitis, sinusitis, nasal congestion, cold and flu, and other related issues. The main end-user groups comprise pharmacies or drugstores, online retail platforms, hospitals and clinics, and supermarkets or hypermarkets.

The decongestants market research report is one of a series of new reports from The Business Research Company that provides decongestants market statistics, including the decongestants industry global market size, regional shares, competitors with the decongestants market share, detailed decongestants market segments, market trends, and opportunities, and any further data you may need to thrive in the decongestants industry. This decongestants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The decongestants market size has grown strongly in recent years. It will grow from $18.63 billion in 2024 to $20.39 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth during the historic period can be attributed to the rising prevalence of the common cold, increased use of over-the-counter medications, heightened awareness of self-medication, expansion of pharmaceutical retail networks, and a growing number of allergic rhinitis cases.

The decongestants market size is expected to see strong growth in the next few years. It will grow to $28.94 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. Growth during the forecast period can be attributed to the increasing demand for combination drugs, improved healthcare access in emerging markets, a growing preference for nasal sprays, an expanding elderly population, and the rising adoption of online pharmacies. Key trends expected in this period include technological advancements in drug delivery systems, innovations in pediatric formulations, development of extended-release decongestants, research into allergy-specific treatments, and innovations in natural and herbal alternatives.

The rising incidence of allergies, colds, and sinusitis is expected to drive the growth of the decongestants market moving forward. Allergies are immune responses to harmless substances, colds are viral infections that cause respiratory symptoms, and sinusitis is inflammation of the sinuses often triggered by infections or allergies. The increase in these conditions is linked to growing air pollution and environmental irritants. Decongestants aid in managing allergies, colds, and sinusitis by relieving nasal congestion, reducing inflammation in the nasal passages, improving airflow, easing breathing difficulties, and enhancing patient comfort. For example, in December 2023, USAFacts, a US-based nonprofit organization, reported that during the 2022-2023 US flu season, about 31.9 million people experienced flu symptoms, with nearly 85% of cases occurring between October and January. Thus, the rising incidence of allergies, colds, and sinusitis is fueling growth in the decongestants market.

Leading companies in the decongestants market are focusing on expanding over-the-counter nasal decongestant offerings, such as fast-acting sprays, to provide quick and effective relief from nasal congestion, thereby improving user comfort and treatment results. A fast-acting spray is a nasal spray that offers rapid relief by quickly reducing nasal congestion soon after use. For example, in August 2024, Manx Healthcare Ltd., a UK-based pharmaceutical firm, launched the Xylometazoline Decongestant Nasal Spray as part of its strategy to grow its respiratory care portfolio. This fast-acting, over-the-counter product is specifically designed to relieve nasal congestion caused by conditions like colds, sinusitis, and allergic rhinitis. The launch highlights the company's dedication to offering accessible, high-quality self-care treatments while meeting growing consumer demand for effective decongestants that deliver rapid, long-lasting relief with ease of use.

In October 2023, Haleon plc, a UK-based pharmaceutical company, collaborated with AptarGroup Inc. to develop a new generation of nasal sprays. This partnership aims to transform nasal congestion treatment by integrating innovative microdroplet and Lateral Control System pump technologies to provide a more comfortable, effective, and user-friendly nasal spray experience. The goal is to overcome common usage barriers and improve relief for patients suffering from colds, allergic rhinitis, and sinusitis. AptarGroup, Inc., a US-based company, specializes in designing and manufacturing drug delivery and dispensing technologies, including those for nasal decongestants.

Major players in the decongestants market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Cipla Ltd., Helen of Troy Limited, Prestige Consumer Healthcare Inc., Orifarm Group A/S, Pharmascience Inc., Beximco Pharmaceuticals Ltd., Reckitt Benckiser Group plc, AdvaCare Pharma, Anish Chemicals, Marinomed Biotech AG.

North America was the largest region in the decongestants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in decongestants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the decongestants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The decongestants market consists of sales of oral decongestants, topical or nasal decongestants, selective alpha-adrenergic agonists, and sympathomimetic amines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Decongestants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on decongestants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for decongestants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The decongestants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Decongestants Market Characteristics

3. Decongestants Market Trends And Strategies

4. Decongestants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Decongestants Growth Analysis And Strategic Analysis Framework

6. Decongestants Market Segmentation

7. Decongestants Market Regional And Country Analysis

8. Asia-Pacific Decongestants Market

9. China Decongestants Market

10. India Decongestants Market

11. Japan Decongestants Market

12. Australia Decongestants Market

13. Indonesia Decongestants Market

14. South Korea Decongestants Market

15. Western Europe Decongestants Market

16. UK Decongestants Market

17. Germany Decongestants Market

18. France Decongestants Market

19. Italy Decongestants Market

20. Spain Decongestants Market

21. Eastern Europe Decongestants Market

22. Russia Decongestants Market

23. North America Decongestants Market

24. USA Decongestants Market

25. Canada Decongestants Market

26. South America Decongestants Market

27. Brazil Decongestants Market

28. Middle East Decongestants Market

29. Africa Decongestants Market

30. Decongestants Market Competitive Landscape And Company Profiles

31. Decongestants Market Other Major And Innovative Companies

32. Global Decongestants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Decongestants Market

34. Recent Developments In The Decongestants Market

35. Decongestants Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기